Cervical cancer is the leading cause of cancer mortality for women in the developing world, where 80% of cases occur, and it remains a significant health problem in parts of the United States (U.S.) like Appalachia, the Texas/Mexico border, and the inner cities. The introduction of the Papanicolaou smear and organized screening programs have decreased both the incidence and mortality of cervical cancer in every country where established. The infrastructure needed to maintain these screening programs is both large and expensive. Despite its enormous success, the Papanicolaou smear has a sensitivity of 60% and specificity of 90%. Our group is assessing emerging technologies in both the developed and developing world. Our goal is to improve the screening and detection of cervical cancer and its precursors using optical technologies and molecular imaging. We have focused on decreasing health care costs and patient anxiety in the developed world and in the creation of devices that automate detection and reduce infrastructure in the developing world. The introduction of HPV vaccines may reduce the incidence of cervical cancer in North America over the next twenty years. There is much left to study about the effectiveness, duration, and administration of the vaccine. Visual Inspection with Acetic Acid, or VIA, has been introduced as replacement for the Papanicolaou smear in low resource settings. VIA involves the use of vinegar on the cervix in order to identify keratinized lesions. While VIA has the enormous advantage of being performed in real-time, it is difficult to quality-assure. In Project 3, we will conduct five clinical trials: training and validation of a classification algorithm for a multispectral digital colposcope (MDC) in 677 patients, examination of the interaction of a spectroscopic point probe and the MDC in order to derive a combined algorithm for this two-par device in 128 patients, a pilot study of a battery-powered and low-cost diagnostic imaging aid (DIA) in 60 patients, a pilot study of an in vivo confocal microscope in 60 patients, and a pilot study of a contrast agent (determined to be optimal by a trial in Project 1) in 60 patients. In order to optimize the trials, only patients with known high-grade cervical lesions are being recruited at five clinical sites: the British Columbia Cancer Agency, M.D. Anderson Cancer Center, Lyndon Baines Johnson County Hospital, Ben Taub General Hospital, and the Baylor College of Medicine.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
7P01CA082710-13
Application #
8706057
Study Section
Special Emphasis Panel (ZCA1-RPRB-7)
Project Start
Project End
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
13
Fiscal Year
2014
Total Cost
$183,417
Indirect Cost
$14,657
Name
Brookdale University Hospital & Medical Center
Department
Type
DUNS #
063864656
City
Brooklyn
State
NY
Country
United States
Zip Code
11212
Nghiem, Van T; Davies, Kalatu R; Beck, J Robert et al. (2016) Overtreatment and Cost-Effectiveness of the See-and-Treat Strategy for Managing Cervical Precancer. Cancer Epidemiol Biomarkers Prev 25:807-14
Nghiem, Van T; Davies, Kalatu R; Chan, Wenyaw et al. (2016) Disparities in cervical cancer survival among Asian-American women. Ann Epidemiol 26:28-35
Yamal, Jose-Miguel; Guillaud, Martial; Atkinson, E Neely et al. (2015) Prediction using hierarchical data: Applications for automated detection of cervical cancer. Stat Anal Data Min 8:65-74
Montealegre, Jane R; Landgren, Rachel M; Anderson, Matthew L et al. (2015) Acceptability of self-sample human papillomavirus testing among medically underserved women visiting the emergency department. Gynecol Oncol 138:317-22
Nghiem, V T; Davies, K R; Beck, J R et al. (2015) Economic evaluation of DNA ploidy analysis vs liquid-based cytology for cervical screening. Br J Cancer 112:1951-7
Sheikhzadeh, Fahime; Ward, Rabab K; Carraro, Anita et al. (2015) Quantification of confocal fluorescence microscopy for the detection of cervical intraepithelial neoplasia. Biomed Eng Online 14:96
Davies, Kalatu R; Cantor, Scott B; Cox, Dennis D et al. (2015) An alternative approach for estimating the accuracy of colposcopy in detecting cervical precancer. PLoS One 10:e0126573
Li, Gerald; van Niekerk, Dirk; Miller, Dianne et al. (2014) Molecular fixative enables expression microarray analysis of microdissected clinical cervical specimens. Exp Mol Pathol 96:168-77
Wang, Lu; Lee, Jong Soo; Lane, Pierre et al. (2014) A statistical model for removing inter-device differences in spectroscopy. Opt Express 22:7617-24
Scheurer, Michael E; Danysh, Heather E; Follen, Michele et al. (2014) Association of traffic-related hazardous air pollutants and cervical dysplasia in an urban multiethnic population: a cross-sectional study. Environ Health 13:52

Showing the most recent 10 out of 104 publications